October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
October 25, 2023 — For its novel multi-lumen stent system for interventional adjustment of pulmonary blood flow in ...
October 20, 2023 — An international team of scientists has identified nearly a dozen genes that contribute to calcium ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 18, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...
October 17, 2023 — Scientists from The Florey are among the world’s leading stroke experts who have mapped out how ...
October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...
October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...
October 12, 2023 — Royal Philips, a global leader in health technology, and the World Stroke Organization (WSO), the ...
October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...
October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...
October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interim recruitment results for the ...
October 10, 2023 — The recipients of two prestigious awards — the Career Achievement Award and the TCT Geoffrey O ...
The global incidence of non-communicable diseases (NCDs) is currently around 40 million cases a year. Of that total ...